Provided by Tiger Trade Technology Pte. Ltd.

Kura Oncology

12.86
+0.20501.62%
Volume:939.16K
Turnover:11.96M
Market Cap:1.14B
PE:-3.82
High:12.92
Open:12.54
Low:12.43
Close:12.65
52wk High:13.90
52wk Low:7.36
Shares:88.77M
Float Shares:70.60M
Volume Ratio:0.35
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3668
EPS(LYR):-3.1784
ROE:-167.71%
ROA:-31.30%
PB:23.56
PE(LYR):-4.04

Loading ...

Kura Oncology announces annual shareholder meeting via webcast

Reuters
·
Apr 11

Kura Oncology to present FIT-001 darlifarnib-cabozantinib data in pretreated kidney cancer

Reuters
·
Apr 09

Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026

GlobeNewswire
·
Apr 09

Kura Oncology grants inducement stock options for 153,750 shares under 2023 plan

Reuters
·
Apr 03

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 03

Kura Oncology Inc : Mizuho Cuts Target Price to $25 From $30

THOMSON REUTERS
·
Mar 25

Kura Oncology Is Maintained at Outperform by Mizuho

Dow Jones
·
Mar 25

Kura Oncology price target lowered to $25 from $30 at Mizuho

TIPRANKS
·
Mar 24

Kura Oncology Is Maintained at Buy by UBS

Dow Jones
·
Mar 14

UBS Trims Price Target on Kura Oncology to $15 From $16, Maintains Buy Rating

MT Newswires Live
·
Mar 13

Kura Oncology price target lowered to $15 from $16 at UBS

TIPRANKS
·
Mar 13

Kura Oncology (KURA) Receives a Hold from Guggenheim

TIPRANKS
·
Mar 07

Kura Oncology Is Maintained at Outperform by Wedbush

Dow Jones
·
Mar 06

Kura Oncology reports inducement grants under Nasdaq listing rule

TIPRANKS
·
Mar 06

BRIEF-Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Mar 06

Kura Oncology Reports Inducement Stock Option Grants for Four New Employees

Reuters
·
Mar 06

Analysts Conflicted on These Healthcare Names: Atea Pharmaceuticals (AVIR), InnovAge Holding (INNV) and Kura Oncology (KURA)

TIPRANKS
·
Mar 06

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Kura Oncology (KURA)

TIPRANKS
·
Mar 06

Wedbush Cuts Kura Oncology Price Target to $36 From $38, Outperform Rating Maintained

MT Newswires Live
·
Mar 06

Kura Oncology: Early KOMZIFTI Launch Momentum, Robust AML Data, and Strong Cash Runway Underpin Buy Rating

TIPRANKS
·
Mar 06